Therapeutic agent for disc herniation
    18.
    发明授权
    Therapeutic agent for disc herniation 有权
    椎间盘突出症治疗剂

    公开(公告)号:US09463225B2

    公开(公告)日:2016-10-11

    申请号:US14491792

    申请日:2014-09-19

    摘要: The present invention provides a therapeutic agent for disc herniation, which has extremely few adverse side effects, can achieve a prolonged pain-ameliorating effect when administered in only a single dose, and can exhibit a high therapeutic effect and high safety in clinical applications. The present invention relates to a therapeutic agent for disc herniation, which is characterized by containing chondroitinase ABC as an active ingredient and being administered in such a manner that the ingredient can be administered into a human disk in an amount of 1-8 units per disk.

    摘要翻译: 本发明提供了一种椎间盘突出症治疗剂,其具有极少的副作用,仅在单一剂量下施用时可达到延长的疼痛改善效果,并且在临床应用中可表现出高治疗效果和高安全性。 椎间盘突出治疗剂本发明涉及椎间盘突出症治疗剂,其特征在于含有软骨素酶ABC作为活性成分,并且以这样的方式给药,使得该成分可以以每个盘1-8个单位的量施用于人体盘 。